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ABSTRACT
OBJECTIVES: To investigate the molecular epidemiology of multidrug resistant (MDR) Acinetobacter 
baumannii isolates collected from patients in two Bulgarian Hospitals (H1, H2) during the period 2005–
2012. 
MATERIALS AND METHODS: A total of 93 nonduplicate MDR A. baumannii isolates collected from 
Intensive care units (ICUs) and surgical wards were studied. Antimicrobial susceptibility was tested by VI-
TEK 2 (bioMérieux, Marcy l’Etoile) and Phoenix (BD) and the results were interpreted according to the cur-
rent CLSI guidelines. Detection of carbapenemase encoding genes was performed by PCR. Isolates were gen-
otyped by PFGE and rep-PCR DiversiLab system (bioMerieux) and compared against a library of A. bau-
mannii strains representing the international clones (IC) 1–8.
RESULTS: Twenty seven isolates were carbapenem resistant and were associated with OXA-23 and OXA-58 
enzymes. The majority of the investigated isolates (n=65) clustered with ICs 1, 2 and 8. Twenty five  isolates 
from H2, collected during the period 2005–2007, did not cluster with any of the representative strains for 
the ICs 1–8 and formed a separate unique clone, which was found to persist in 2012. 
CONCLUSIONS: Our results reveal the epidemic and endemic potential of A. baumannii as well as persis-
tence of clones over time. Multidrug resistance in A. baumannii from the investigated Bulgarian hospitals 
was associated with intrahospital dissemination of IC1, 2 and 8 and with unique local clones.
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INTRODUCTION
Acinetobacter baumannii is a major nosocomial 
pathogen, particularly in the intensive care unit 
(ICU) setting. This bacterial species is characterized 
by its resistance to multiple antimicrobial agents, 
propensity for clonal spread and involvement in 
numerous hospital outbreaks. Eight A. baumannii 
international clones (IC 1-8) have been identified. IC 
2 is the most widespread and is often associated with 
carbapenem resistance (1). 
48 Scripta Scientifica Medica, vol. 46, No 3, 2014, pp. 47-50
Copyright © Medical University of Varna
Molecular epidemiology of multidrug resistant Acinetobacter baumannii clinical isolates from two bulgarian hospitals
A. baumannii is one of the most commonly
isolated multidrug resistant (MDR) pathogens in 
the University Hospital “Saint Marina” (H1) and 
Municipal Hospital “Saint Anna” (H2) in Varna, 
Bulgaria during the last decade. The objective of this 
study was to investigate the molecular epidemiology 
of MDR A. baumannii isolates collected from patients 
in the two hospitals during the period 2005/2007 and 
2010/2012 with the aim to identify the predominant 
clonal lineages circulating in the hospitals and their 
mechanism of carbapenem resistance. 
MATERIAL AND METHODS
A total of 93 nonduplicate MDR isolates of 
A. baumannii, obtained from patients admitted in
ICUs (58%) and surgical wards (42%), were investi-
gated. The isolates were recovered predominantly
from wound specimens (46%) and tracheal aspirates
(42%). Sixty four isolates were collected in the peri-
od 2005–2007; 3 and 26 isolates – in 2010 and 2012
respectively. Species identification was performed by
gyrB multiplex PCR (2). Antimicrobial susceptibility
was tested by VITEK 2 (bioMérieux, Marcy l’Etoile,
France) and Phoenix (BD) and the results were in-
terpreted according to the current CLSI guidelines
(3). The isolates were genotyped by PFGE and rep-
PCR DiversiLab Microbial Typing System (bioMéri-
eux, Nürtingen, Germany) and compared against a
library of A. baumannii strains representing the In-
ternational clones 1-8 (4,5). Detection of carbapen-















formed by PCR (6,8).
RESULTS AND DISCUSSION
Twenty six isolates (28%) were imipenem and 
meropenem resistant and resistant to most of the 
antibiotics tested, except colistin. One isolate (bla-
OXA-58-like 
positive) demonstrated resistance to imi-
penem (MIC = 16 µg/ml), but susceptibility to me-
ropenem (MIC = 4 µg/ml). Most isolates were resis-
tant to β-lactams other than carbapenems, including 
piperacillin – 100%; ceftazidime – 98.9%; cefepime 
– 97.8% and ampicillin/sulbactam – 92.5%, as well
as to non-β-lactam antibiotics: gentamicin – 91.4%;
amikacin – 87%; ciprofloxacin – 91.4% and trime-
thoprim/sulfamethoxazole – 87%.
In the group of isolates from H2 (n=68), PFGE 
of the ApaI-digested genomic DNA identified 6 pul-
sotypes (A-F), two of which were predominant (A, B) 
(Table 1).  Rep-PCR confirmed this clustering. Pulso-
type A was represented by 25 carbapenem suscepti-
ble (CS) isolates, recovered from five different wards 
during the period 2005-2007: ICU, Orthopedic sur-
gery, Thoracic surgery,  II General surgery and  Neu-
rosurgery. Representative isolates for pulsotype A did 
not cluster with any of the major international clonal 
lineages and formed a separate, unique clone, dom-
inant during the period 2005–2007. This clone was 
found to persist in 2012, but was represented by car-
bapenem resistant (CR) isolate (Fig. 1). 
Pulsotype B was represented by 22 CS and one
 CR isolate, all collected during 2005–2007 from Or-
thopedic surgery, I and II General surgery wards and 
the ICU. Two environmental isolates (working sur-
faces and sheets) from the ICU and Orthopedic sur-
gery were found to express identical PFGE pulso-
type B as that of the clinical isolates, demonstrat-
ing the role of the hospital environment as an im-
portant factor for transmission and dissemination of 
this nosocomial pathogen. Representative isolates for 
pulsotype B were found to correspond to IC1 (Fig-
ure 1). In 2012 no isolates were found to cluster with 
IC1. Both dominant clones A and B have spread in 
parallel among several wards of the hospital dur-
ing the studied period, indicating nosocomial cross 
transmission. 
Pulsotype D was detected in 9 CS isolates, all 
recovered from five different wards (ICU, Gynecol-
ogy, Orthopedic surgery, I and II General surgery 
wards) but only in 2005. Representative isolates for 
this pulsotype cluster with IC8 (Figure 1). Isolates be-
longing to IC8 were not found in 2012. 
Pulsotype E was identified in 5 CS isolates, col-
lected from ICU, Orthopedic surgery and II Gener-
al Surgery ward during the period 2006–2007. Rep-
resentative isolates of pulsotype E cluster with IC2. 
Although the first IC2 isolate was recovered in 2006 
in Orthopedic surgery, this clone was also detected 
in 2012 but was already represented by CR A. bau-
mannii isolates. The isolates from H1 (22 CR and 3 
CS), recovered predominantly from the surgical ICU 
(n=23) during the period 2010–2012, also clustered 
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with IC2 (Figure 1). Pulsotype C and F from H2 rep-
resented single isolates. 
All isolates had the intrinsic bla
OXA-51-like 
gene. All 





 was detected in twenty six CR 
isolates and bla
OXA-58-like
 in one CR isolate. bla
OXA-58-like
 
was also detected in one CS isolate. In 2005/2007, the 
only acquired bla
OXA-like 
in A. baumannii was bla
OXA-58-
like
. In 2012, only isolates harbouring bla
OXA-23-like
 were 
detected. With one exception, no acquired bla
OXA-like
 
was detected in CS isolates. 
CONCLUSIONS
This study demonstrates the epidemic and en-
demic potential of A. baumannii. A total of 70% of 
the investigated isolates from both hospitals cluster 
with IC1, 2 and 8, confirming the wide geographi-
cal distribution of these epidemic clonal lineages. In 
2005–2007, MDR in A. baumannii in H2 was asso-
ciated with coexistence and intrahospital dissemina-
tion of the unique local clone A and with IC1, IC2 
and IC8. Clone A and IC2 were found still to persist 
in 2012. In this regard, the problem of MDR A. bau-
mannii is not only related to the international clon-
al lineages but also to other successfully disseminat-
ed genotypes. In this study, carbapenem resistance in 
the investigated Bulgarian hospitals, mediated main-
ly by the acquired OXA-23 carbapenemase, was as-
sociated with both persisting hospital clones A and 
IC2.
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Table 1. Pulsotype, year of isolation and clustering with the major ICs.
H1, Hospital 1; H2, Hospital 2; CR, carbapenem resistant; Unc, unclustered with IC; ICU, intensive care unit; TS, Thoracic surgery, 
GS I, I General surgery; GSII, II General surgery; NS, Neurosurgery; OS, Orthopedic surgery; G, Gynecology.
Fig. 1. Dendrogram and rep-PCR profiles of 21 A. 
baumannii isolates from H1 and H2 and clustering with 
the major ICs.
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